Immunofluorescence studies revealed that gemcitabine caused LC3B puncta (LC3B-II) to accumulate in the pancreatic cancer cell line MIA PaCa-2 (Fig.1A). This evidence concerns the gene MAP1LC3B and familial pancreatic carcinoma.